RE: Valuation1 Dec 2020 18:48
I believe they're aiming to produce 100,000 treatments every month throughout 2021, as Richard Marsden said.
But aside from the trial, that doesn't mean they'll be using them before approval. And I don't think that will come before the analysis of phase 3 results, hence the timeline I'm anticipating below.